The selaginellin derivatives are a type of novel natural pigments with an unusual alkynyl phenol skeleton from the genus Selaginella. Some of these natural compounds were previously reported to show important bioactivities, including anticancer activity, cardiovascular protection and phosphodiesterase-4 inhibition. We designed and synthesized fifteen biphenyl-containing diaryl acetylene derivatives mimicking the skeleton of natural alkynyl phenols. In MTT assay in cancer cells, compounds 1c, 2d, 2g, 2h, 2i and 2j exhibited potent antiproliferative activity. The evaluation of Hypoxia Inducible Factor-1 (HIF-1) pathway inhibitory activity in dual luciferase assay demonstrated that most tested compounds exhibited moderate to good activities. Compounds 1a, 2f and 2h displayed high HIF-1 inhibitory activities and relatively low cytotoxicity, demonstrating great potential as HIF-1 inhibitors. These results afford a new strategy for the discovery of new HIF-1 inhibitors and anti-proliferative agents from natural or synthetic diaryl acetylene derivatives.
Introduction
Natural products and their synthetic derivatives have served as a consistent source of valuable new drug leads for centuries, and natural products with bioactive pharmacophores are biologically validated starting points for the development of new drugs. 1 In the last decade, a type of novel natural pigment with an unusual alkynyl phenol skeleton has been successively isolated from the genus Selaginella, mainly from S. tamariscina and S. pulvinata which are the two qualied species listed in Chinese Pharmacopoeia and used as traditional Chinese medicines for the treatment of dysmenorrhea, abdominal mass and traumatic injury. The pharmacological investigations of the genus Selaginella have revealed that it has anticancer, antivirus, antioxidant and anti-inammatory activities. 2 The phytochemical investigations of the genus Selaginella have led to the identication of more than forty natural alkynyl phenols hitherto, including selaginellin, 3 selaginellins A-W, [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] selariscinins A-D, 14, 17 and selaginpulvilins A-L. [20] [21] [22] [23] [24] [25] All these natural products possess unique skeletons characterized by biphenyl-containing diaryl acetylene, as shown in Fig. 1 .
The biological activities of these alkynyl phenol compounds have been demonstrated to involve hypoglycemic, 14 antiinammatory, 26 and anti-oxidant 27 activity, cardiovascular protection, 28 anticancer effects, 9 and neuroprotective effects. 18, 29, 30 Selaginellin and selaginellins A, C, M, N, O, Q have been reported to be cytotoxic against U251, HeLa, MCF-7 and BGC-823 tumor cells. [9] [10] [11] Selaginpulvilins A-L, with an unprecedented 9,9-diphenyl-1-(phenylethynyl)-9H-uorene skeleton, exhibit remarkable phosphodiesterase-4 inhibitory activity with IC 50 of 0.011-1.38 mM. 20, 22, 25 The previous work in our laboratory on the bioactive constituents from the genus Selaginella revealed selaginellins A and B were moderately cytotoxic against H322 cell, and selaginellin A displayed inhibitory activity on hypoxia inducible factor-1 (HIF-1) transcription in dual luciferase reporter assay (unpublished). HIF-1 is a central regulator involved in detection and adaption to cellular oxygen stress through regulation of the hypoxic transcriptional program in angiogenesis, erythropoiesis, and metabolism. 31 The HIF-1 pathway is involved in many diseases, including anemia, ischemia, most tumors, and other hypoxicischemic diseases, making HIF-1 an attractive target for therapeutic application. 32 A considerable proportion of solid tumors are induced by hypoxia which results in overexpression of the HIF-1 pathway. Moreover, overexpression of the HIF-1 pathway has been correlated with poor prognosis, invasive tumor growth, and resistance to radiation for tumor patients. 33 Therefore, the inhibition of HIF-1 has been identied as an effective therapeutic strategy for various solid tumors.
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The unique skeletons associated with important bioactivities of this family of alkynyl phenols have attracted great attention of scientists from elds of organic synthesis and medicinal chemistry. Up to now, the reports on the total synthesis of natural alkynyl phenols are rare and all focus on the diaryluorene derivatives selaginpulvilins, 21, [23] [24] [25] whereas the total synthesis of selaginellins and selariscinins has not been reported yet. In our effort to develop synthetic method for selaginellins, we achieved the precursors of selaginellin N (1a-1d) with the skeleton of selariscinin D and selaginellin S. The difficulty in the synthesis of selaginellins with moiety of benzyl para-quinone methide is considered to result from the large steric hindrance of polycyclic skeleton. Considering the unique diaryl acetylene skeleton as a good privileged structure, we designed and synthesized a series of non-natural diaryl acetylene derivatives (2a-2j) analogous to selaginellins but with less steric hindrance. Herein we report the synthesis of this family of diaryl acetylene derivatives, their cytotoxic activity against tumor cells and HIF-1 inhibitory activity.
By analyzing the structures of selaginellin and its reported derivatives, P. F. Tu et al. proposed a potential biosynthetic pathway of selaginellin and its derivatives. 35 We compared the different skeletons of natural alkynyl phenols as displayed in Fig. 1 and presumed that the formation of selaginellin N analogues might undergo the intermediates of selariscinin D analogues, selaginellin S analogues and selariscinin B analogues successively. Based on this presumption, a retrosynthetic analysis of selaginellin N was established as shown in Scheme 1, where selariscinin D analogues were synthesized starting with halogenated benzoate via the Suzuki coupling and Sonogashira reaction.
Results and discussion

Chemistry
With the aim to synthesize selaginellin N, we rst synthesized 1a using o-bromobenzoic acid as the starting material via iodization, methyl esterication, regioselective Suzuki coupling reaction and Sonogashira reaction (Scheme 2). Using THF-H 2 O as the solvent in Suzuki reaction, compound 6 was obtained under mild condition with a better yield than reported.
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Compound 1a has a skeleton similar to selariscinin D, 15 which exhibited stimulatory effect on glucose uptake in 3T3-L1 adipocyte cells and potent inhibitory effect against PTP1B.
We attempted to synthesize selaginellin N through the demethylation and dehydration of triphenyl methol intermediate 1f. However, the nucleophilic addition of 1a with 4-methoxyphenyl bromide under the presence of n-butyllithium produced the diphenyl ketone 1c instead of triphenyl methol (Scheme 3). The steric hindrance of 1c is presumably the dominated factor to prevent the further reaction to produce triphenyl methol. We tried using the more reactive acyl chloride, which was prepared via the hydrolysis and chlorination of 1a. As a result, 1c was still yielded as the major product and no product of triphenyl methol was detected. Although the efforts to synthesize selaginellin N failed, the diphenyl ketones 1c and 1d are still important products since they bear the same skeleton with selaginellin S, which showed inhibitory effects against hepatitis B virus gene expression and replication.
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During the demethylation of 1a with boron tribromide, an unexpected isocoumarin 1e was obtained as the main product.
In view of the high steric hindrance in natural selaginellins, we designed and synthesized a series of selaginellin analogs (2a-2j) with a different attached position of 4-methoxyl phenylacetylene group (Scheme 4). Using the similar synthetic approach of 1a, 2a was obtained with a high yield starting with o-iodobenzoic acid via bromination, methyl esterication, regioselective Suzuki coupling and Sonogashira reaction. Compared with the yield of 1a in Sonogashira reaction, the yield of 2a was greatly increased due to less side reaction between meta-substituted carboxylic ester and alkynyl.
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In the next nucleophilic addition of 2a, using 4-methoxyphenylmagnesium bromide as the nucleophilic regent yielded a diphenyl ketone product 2c, whereas using 4-methoxyphenyl bromide under the presence of n-butyllithium produced the triphenyl methol 2e along with a side product 2f (Scheme 5). As we expected, the less steric hindrance of 2a than that of 1a allowed the production of triphenyl methol under the same conditions.
As Scheme 6 described, the demethylation of 2e with BBr 3 under different conditions gave three different products. By controlling the reaction temperature at À83 C and using small equivalents of BBr 3 , we obtained two demethylation products 2g and 2h. When the reaction temperature was set at 0 C, the diaryluorene derivative 2i, the analog of selaginpulvilin K, was yielded, probably from the Friedel-Cras reaction under the catalysis of boron tribromide. In order to hydrolyze more methyl groups, we used excessive equivalents of BBr 3 and slowly raised the reaction temperature from À83 C to 0 C. As we expected, the demethylation and dehydration occurred simultaneously to produce the benzyl para-quinone methide derivative 2j which resembles selaginellin N in molecular skeleton.
Biological results
2.2.1. MTT assay for tumor cell growth inhibition. The in vitro cytotoxic activity of the synthesized compounds against MCF-7, HepG2 and L-O2 cells was tested using MTT assay with cisplatin as a positive control. From the experiment data listed in Table 1 , the tested compounds with different skeletons exhibited diverse cytotoxic effects. Compounds 1a-1e showed weak cytotoxic effects with the exception of 1c (IC 50 ¼ 7.18 mM against MCF-7). Among compounds 2a-2j, 2a-2f showed weak cytotoxic effects with the exception of 2d, while 2g-2j showed moderate cytotoxic effects. The cytotoxicity of 2d was more potent than that of 1d, suggesting that the attached position of phenylacetylene greatly inuenced their cytotoxicity. Compounds 2g and 2h showed much more cytotoxic effects Scheme than their methylated precursor 2e, suggesting the presence of phenolic hydroxyl favors the antitumor activity of these compounds. Compounds 2h, 2i and 2j showed similar cytotoxic effects although they possess different scaffolds. Interestingly, compound 2j with a non-natural skeleton showed more cytotoxic effects than its natural analogs selaginellins, enabling 2j to be a more promising anti-tumor agent due to its advantage of easier synthesis. 2.2.2. Cell-based reporter assays for hypoxia-inducible factor-1 (HIF-1) inhibition. Almost all solid tumors have a common feature, that is, hypoxia, resulting in overexpression of the HIF pathway in the tumor microenvironment. 37 Therefore, HIF inhibition has been suggested to be an attractive and promising therapeutic strategy for various solid tumors. To date, the mechanism underlying the anticancer effects of alkynyl phenol derivatives has not been investigated. We here explored the effect of synthesized alkynyl phenol derivatives on HIF pathway by dual luciferase reporter system. The carborane derivative 11, an HIF-1 inhibitor reported by Nakamura, 38 was used as a reference substance. As the data listed in Table 2 , all tested compounds exhibited moderate to strong HIF inhibitory activities except 2j. Compounds 1a, 2f and 2h displayed comparative HIF inhibitory activities and low cytotoxicity compared with compound 11. Different from the rest synthetic derivatives, compound 2j showed potent anti-proliferative effect, but little HIF inhibitory activity was determined, suggesting a distinct effect resulting from its para-quinone methide moiety.
Experimental section
Chemistry
All chemicals and solvents were commercially available, at least reagent grade. Compound 1a (186.5 mg, 0 .50 mmol) was dissolved in 2 mL dry dichloromethane in a 10 mL chicken heart ask. Then the reaction mixture was stirred in an ice water bath and boron tribromide (470 mL, 4.97 mmol) was added. Aer being stirred for 2 hours, 3 mL diethyl ether was added. The reaction mixture was stirred for 20 min and saturated sodium bicarbonate solution was slowly added. The reaction mixture was diluted with ethyl acetate and washed with saturated brine. The combined extract was dried by anhydrous sodium sulfate. Ethyl acetate was evaporated under vacuum. The residue was puried by silica gel chromatography to afford compound 1e (54.9 mg, 33%). Light yellow solid; mp 297-299 C; the purity of the compound was detected by analytical HPLC to be over 95%. 0 g ), 20 mL methanol and 5 mL water were added to a 100 mL round bottom ask. Then the reaction mixture was reuxed at 100 C for 2 hours. The mixture was cooled to room temperature. The solvent was evaporated under vacuum. The residue was diluted with ethyl acetate and washed with dilute hydrochloric acid and saturated brine. The combined extract was dried by anhydrous sodium sulfate. Ethyl acetate was evaporated under vacuum. The residue was puried by silica gel chromatography to afford compound 2b (354.5 mg, 99%). White solid; mp 191-193 C; the purity of the compound was detected by analytical HPLC to be over 95%. Compound 2c (319.2 mg, 0.71 mmol) was dissolved in 5 mL dry dichloromethane added in a 50 mL round bottom ask. Then the reaction mixture was stirred in an ice water bath and boron tribromide (340 mL, 3.6 mmol) was added. Aer being stirred for 30 min, 10 mL diethyl ether was added. The reaction mixture was stirred for 20 min and saturated sodium bicarbonate solution was slowly added. Then the reaction mixture was diluted with ethyl acetate and washed with saturated brine. The combined extract was dried by anhydrous sodium sulfate. Ethyl acetate was evaporated under vacuum. The residue was puried by silica gel chromatography to afford compound 2d (180.7 mg, 61%). White solid; mp 229-231 C; the purity of the compound was detected by analytical HPLC to be over 95%. 1 was dissolved in 2 mL dry dichloromethane in a 10 mL chicken heart ask. Then the reaction mixture was stirred at À83 C and boron tribromide (140 mL, 1.4 8 mmol) was added. Aer being stirred for 1 hour, 5 mL diethyl ether was added. The reaction mixture was stirred for 20 min and saturated sodium bicarbonate solution was slowly added. Then the reaction mixture was diluted with ethyl acetate and washed with saturated brine. The combined extract was dried by anhydrous sodium sulfate. Ethyl acetate was evaporated under vacuum. The residue was puried by silica gel chromatography to afford compound 2g (40.6 mg, 30%) and compound 2h (66.0 mg, 50%). The purity of the two compounds was detected by analytical HPLC to be over 95%. 86 (m, 6H), 6.68-6.74 (m, 4H), 3.87 (s, 1H) 3.1.18. 7-((4-Hydroxyphenyl)ethynyl)-9,9-bis(4-methoxyphenyl)-9H-uoren-2-ol (2i). Compound 2e (155.7 mg, 0.28 mmol) was dissolved in 2 mL dry dichloromethane in a 10 mL chicken heart ask. Then the reaction mixture was stirred in an ice water bath and boron tribromide (110 mL, 1.16 mmol) was added. Aer being stirred for 30 min, 5 mL diethyl ether was added. The reaction mixture was stirred for 20 min and saturated sodium bicarbonate solution was slowly added. Then the reaction mixture was diluted with ethyl acetate and washed with saturated brine. The combined extract was dried by anhydrous sodium sulfate. Ethyl acetate was evaporated under vacuum. The residue was puried by silica gel chromatography to afford compound 2i (38.8 mg, 27%). White solid; mp 125-127 C; the purity of the compound was detected by analytical HPLC to be over 95%. 1 MTT dissolved in phosphate buffer solution). Aer postincubation at 37 C for 4 hours, the medium was discarded followed by adding 150 mL DMSO (Sigma-Aldrich, St. Louis, USA). The plates were then vortexed for 10 min for complete dissolution. The optical absorbance was measured at 570 nm. The data represented the mean of three independent experiments in triplicate and were expressed as mean AE SD. The IC 50 value was dened as the concentration at which 50% of the cells could survive. 3.2.2. Cell-based reporter assays for hypoxia inducible factor-1 (HIF-1) inhibition. HeLa cells expressing HREdependent rey luciferase reporter construct (HRE-Luc) and constitutively expressing CMV-driven Renilla luciferase reporter with SureFECT transfection reagent were established with Cignal™ Lenti Reporter (SABiosciences, Frederick, MD) according to the manufacturer's instructions. The consensus sequence of HRE was 5 0 -TACGTGCT-3 0 from the erythropoietin gene. Cells stably expressing the HRE-reporter gene were selected with puromycin. The cells were incubated for 12 hours with or without drugs under the normoxic or hypoxic condition (1% O 2 ). Aer incubation, the luciferase assay was performed using a Luciferase Assay System (Promega, Madison, WI) according to the manufacturer's instructions. The drug concentration required to inhibit the relative light units by 50% (IC 50 ) was determined from semi-logarithmic dose-response plots, and the results represent means AE SD of triplicate samples.
H NMR (400 MHz
, DMSO-d 6 ) d 12.98 (s, 1H), 7.79 (d, J ¼ 1.7 Hz, 1H), 7.66 (dd-Methoxy-4-((4-methoxyphenyl)ethynyl)-[1,1 0 - biphenyl]-2-yl)bis(4-methoxyphenyl)methanol (2e); 1-(4 0 - methoxy-4-((4-methoxyphenyl)ethynyl)-[1,1 0 -biphenyl]-2-yl)-1-(4- methoxyphenyl)pentan-1-ol (2f
Conclusion
In conclusion, we designed and synthesized a class of natural product-like biphenyl-containing diaryl acetylenes mimicking natural alkynyl phenols from the genus Selaginella. In MTT assay in cancer cells, compounds 1c, 2d, 2g, 2h, 2i and 2j exhibited potent cytotoxic activity. The evaluation of HIF-1 inhibitory activity demonstrated that all tested compounds exhibited moderate to good activities except 2j. Compounds 1a, 2f and 2h displayed high HIF-1 inhibitory activities and relatively low cytotoxicity, demonstrating their great potential as HIF-1 inhibitors. These results afford us a new strategy for the discovery of new HIF-1 inhibitors and anti-proliferative agents from natural or synthetic diaryl acetylene derivatives.
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